Medical Technology News | MedTech Dive
MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
Abbott ramps up Libre 3 production amid shortages
2024年9月20日 — MedTech industry news. “Essentially, some patients are seeing delays in their scripts getting filled at certain U.S. retail pharmacies due to a low on-shelf inventory, and while there are likely some minor supply issues causing these script delays, demand also has been very strong as Abbott continues to gain share in the U.S.,” Marcus wrote on Thursday.
Abbott and Dexcom are launching the first over-the-counter …
2024年6月26日 — The new devices could allow the companies to reach about 25 million people in the U.S. with Type 2 diabetes who don’t take insulin, 15 million people who have been diagnosed with pre-diabetes and an estimated 85 million people who have undiagnosed pre-diabetes, William Blair analyst Margaret Kaczor Andrew said in an interview.
Roche to buy LumiraDx’s point-of-care technology for $295M
2024年1月2日 — Dive Brief: Roche reached an agreement to acquire LumiraDx’s point-of-care testing technology, the companies announced on Dec. 29. Roche will pay $295 million upfront and an additional amount up to $55 million to fund Lumira’s point-of-care technology platform business until the acquisition closes.
FDA flags 428 spinal cord stimulator patient deaths, urges more …
2020年9月4日 — Dive Brief: FDA on Thursday published a letter to healthcare providers outlining hundreds of reports of deaths and thousands of injuries and malfunctions with spinal cord stimulators, reminding physicians to follow product labels calling for a simulation in patients prior to permanently implanting the SCS devices.. Healthcare providers are supposed to trial the estimated 50,000 devices ...
Synchron brain-computer interface implanted in first 6 US patients
2023年9月6日 — Dive Brief: Synchron, which is developing a brain-computer interface that aims to restore functionality in people with severe paralysis, said Tuesday that six patients have received the implant in the company’s U.S.-based feasibility study. The milestone marks the completion of enrollment in the COMMAND trial, conducted under the first investigational device exemption awarded by the Food and ...
The top medtech trends in 2024 | MedTech Dive
2024年1月31日 — Several Wall Street analysts also pointed to pulsed field ablation (PFA) as an emerging market to watch this year. Medtronic announced the first Food and Drug Administration approval for a PFA system in December, and Boston Scientific recently said it got the green light for its system, launching what is expected to be a competitive space for the next several years as other top companies join ...
Intuitive details launch plan for new da Vinci 5 robot
2024年3月18日 — Intuitive Surgical will roll out the next generation of its market-leading da Vinci surgical robot in a limited launch that will extend into 2025, the company said Monday on a conference call with analysts.
Boston Scientific’s spinal cord stimulators approved for non …
2024年2月7日 — Dive Brief: Boston Scientific has won approval for its Wavewriter spinal cord stimulator (SCS) systems in non-surgical back pain (NSBP).; The U.S. Food and Drug Administration approval expands the label of the Wavewriter systems to cover the treatment of chronic low back and leg pain in people without prior back surgery.
Abbott device approval sets up battle with Medtronic, Nevro for ...
2023年2月6日 — The procedure is covered by most major insurers. While the devices are expensive, some studies show they can decrease long-term health care costs for patients, Mayo Clinic neurologist Dr. Narayan Kissoon wrote in an email. Implanting a spinal cord stimulator can cost $32,000 for Medicare and as much as $58,000 for commercial insurers, according to the Journal of Neurosurgery.